As it has been well accepted that improvement of insulin sensitivity always occurs after reduction of obesity, it can be argued that the observed beneficial metabolic effects upon leucine deficiency in most other studies is likely a result of body weight reduction. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.